Evidence map›Paper›PMID 41816056›Full record

ArticleQuantitative imaging in medicine and surgery2026

Super-resolution and habitat radiomics based computed tomography machine-learning model for prediction of lung invasive adenocarcinoma: a multi-centre study.

Yanqing Ma, Pingshan Zhao, Haoran Chen, Huizhi Ni, Hongxian Gu, Yi Lin, Wenjie Liang

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yanqing Ma *Department of Radiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Pingshan Zhao *Department of Radiology, Shaoxing Hospital of Traditional Chinese Medicine, Shaoxing, China.
Haoran ChenDepartment of Radiology, The First People's Hospital of Tongxiang, Tongxiang, China.
Huizhi NiChangsha Medical University, Changsha, China.
Hongxian GuDepartment of Radiology, Jianyang People's Hospital, Jianyang, China.
Yi LinCancer Center, Department of Radiology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
Wenjie LiangDepartment of Radiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Early differentiation between invasive adenocarcinoma (IAC) and non-IAC pulmonary nodules is crucial for guiding clinical decision-making. Therefore, this study aimed to distinguish IAC from non-IAC pulmonary nodules using intra-tumor radiomics signatures, habitat radiomics analysis, and a combined nomogram by integrating generative adversarial network (GAN) based super-resolution reconstruction. Methods: In this multi-center retrospective study, 858 patients [mean ± standard deviation (SD): 57.635±12.978 years] were enrolled as the training set (Center 1, 501 non-IAC cases Results: The Habitat-Model outperformed Intra-Model (training AUC: 0.893 Conclusions: The spatially resolved habitat radiomics model exhibited higher discriminative accuracy than the classical intra-tumor radiomics model. The combined nomogram framework, which integrated intra-tumor radiomics, habitat radiomics, and significant clinical biomarkers, achieved state-of-the-art performance in IAC stratification. This framework provides a robust tool for precision therapeutic decision-making in pulmonary nodule management.

Indexed as

Adenocarcinomacomputed tomography (CT)habitatlungradiomics

Identifiers

PMID41816056
PMCPMC12971333

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.